🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Enhancing Digitally Delivered Diabetes Education With Real-Time CGM

RecruitingNAAges 18 Years - anyAllScripps Whittier Diabetes Institute
NCT06296550 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The current research study will add continuous glucose monitoring devices to the evidence-based text messaging diabetes education program for patients with type 2 diabetes for 6 months. Results on the effectiveness of this intervention will be compared for non-insulin using patients.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Diagnosed with type 2 diabetes * Are not currently using a CGM * Are not using insulin therapies * Speak English, Spanish or Arabic * Have A1c between 7.5% and 12.0% in last 90 days * Have a cellphone that can receive/send text messages and counts steps Exclusion Criteria: * Are using insulin therapies * Are pregnant * Are currently using a CGM * Are currently participating in another diabetes-related study
💊

What it tests

  • Dulce Digital Text Messaging Intervention
  • CGM Device
📍

Where

1 site
Scripps Whittier Diabetes Institute
San Diego, United States
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy